Trial
NCT04854889
Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Collaborators
—
Condition
Refractory Aplastic Anemia
Intervention
Decitabine
Why stopped
Not achieve the desired effect
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-11